Animal testing remains a principle screening tool in the drug discovery pipeline, but are they reliable and could there be alternatives to replace them?
Animal testing remains a principle screening tool in the drug discovery pipeline, but are they reliable and could there be alternatives to replace them?
No formal scientific education, a single mother, author of 103 scientific papers, the first person to see a corona virus, June Almeida was a tour de force.
Bringing science to life through spectacular images.
Study claims nasal delivery protects first site of infection and produces widespread immune response compared to intramuscular injection.
A research team combats antibiotic-resistant superbugs by administering antibiotics together with metformin.
A study that analyzed data from nearly 15 000 patients with COVID-19 receiving four combinations of chloroquine, hydroxychloroquine, and antibiotics indicates the drug regimen may be doing more harm than good.
Understanding changes to the spike protein’s structure is critical to the development of an effective vaccine.
Identifying patient-specific response to cancer immunotherapy is urgently needed to maximize therapeutic benefit for as many people as possible.
Researchers at the University of Munich have demonstrated a conceptually novel nanocarrier strategy in which the nanoparticles are both the cargo and the carrier.
Scientists engineer a virus known to be be harmless to humans to stimulate an immune response against the coronavirus family in mice.